Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.


Angiogenesis is activated during multistage tumorigenesis prior to the emergence of solid tumors. Using a transgenic mouse model, we have tested the proposition that treatment with angiogenesis inhibitors can inhibit the progression of tumorigenesis after the switch to the angiogenic phenotype. In this model, islet cell carcinomas develop from multifocal… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.